Synapse - Solid Tumor Oncology Division

Results (5219)

Tumor mutation burden and efficacy of targeted therapy in patients with EGFR mutant lung cancers

Meeting Abstract

Offin, M. D.; Rizvi, H.; Tenet, M.; Ni, A.; Sanchez Vega, F.; Kris, M. G.; Rudin, C. M.; Riely, G. J.; Yu, H. A.; Hellmann, M. D.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Circulating tumor DNA in advanced lung cancers: A prospective evaluation of matched therapy and shedding detection

Meeting Abstract

Offin, M. D.; Stephens, D.; Sabari, J. K.; Makhnin, A.; Myers, M.; Ni, A.; Pavlakis, N.; Clarke, S. J.; Tandon, N.; Datta, S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Two-year efficacy and safety update from JAVELIN Merkel 200 part A: A registrational study of avelumab in metastatic Merkel cell carcinoma progressed on chemotherapy

Meeting Abstract

Nghiem, P.; Bhatia, S.; Brohl, A. S.; Hamid, O.; Mehnert, J. M.; Terheyden, P.; Shih, K. C.; Brownell, I.; Lebbé, C.; Lewis, K. D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

HuMab-5B1 (MVT-5873), a mAb targeting sLe(a), in combination with first-line gemcitabine plus nab-paclitaxel (gem/nab-P) for patients with pancreatic cancer (PDAC) and other CA19-9 positive malignancies

Meeting Abstract

O'Reilly, E. M.; Borazanci, E. H.; Yu, K. H.; Varghese, A. M.; Estrella, H.; Kamins, D.; Melink, T.; Dorr, K.; Maffuid, P.; Gutheil, J.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Contessa: A multinational, multicenter, randomized, phase 3 registration study of tesetaxel in patients (Pts) with HER2-, hormone receptor + (HR+) locally advanced or metastatic breast cancer (MBC)

Meeting Abstract

O'Shaughnessy, J.; Piccart-Gebhart, M. J.; Schwartzberg, L. S.; Cortes, J.; Harbeck, N.; Im, S. A.; Rugo, H. S.; Untch, M.; Yardley, D. A.; Bondarenko, I.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission

Meeting Abstract

O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

SU2C-SARC032: A phase II randomized controlled trial of neoadjuvant pembrolizumab with radiotherapy and adjuvant pembrolizumab for high-risk soft tissue sarcoma

Meeting Abstract

Mowery, Y. M.; Ballman, K. V.; Riedel, R. F.; Brigman, B. E.; Attia, S.; Meyer, C. F.; Schuetze, S.; Burgess, M. A.; Chmielowski, B.; Dickson, M. A.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Frequency of actionable cancer predisposing germline mutations in patients with lung cancers

Meeting Abstract

Mukherjee, S.; Zauderer, M. G.; Ravichandran, V.; Kemel, Y.; Mandelker, D.; Pradhan, N.; Zehir, A.; Lipkin, S. M.; Srinivasan, P.; Bandlamudi, C.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

A prospective phase 2/3 multicenter study of (18)F-DCFPyL PET/CT imaging in patients with prostate cancer: Examination of diagnostic accuracy (OSPREY)

Meeting Abstract

Morris, M. J.; Carroll, P.; Probst, S.; Pouliot, F.; Saperstein, L.; Siegel, B. A.; Alva, A. S.; Preston, M. A.; Patnaik, A.; Gorin, M. A.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Phase I study of intermittent high-dose lapatinib alternating with capecitabine for HER2-positive breast cancer with central nervous system metastases

Meeting Abstract

Morikawa, A.; Pentsova, E.; Kemeny, M.; Patil, S.; Li, B. T.; Tang, K.; Fleisher, M.; Van Poznak, C. H.; Norton, L.; Seidman, A. D.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save